Crohn's disease of the small bowel, complicated by primary biliary cirrhosis, Hashimoto thyroiditis, and Raynaud's phenomenon: favorable response of all disorders to adalimumab treatment

We describe the case of a male patient suffering from long-lasting Crohn's disease of the small bowel who developed thyroiditis Hassimoto, Raynaud's phenomenon, and primary biliary cirrhosis, during the course of the underlying bowel disease. It is not clear whether these co-morbidities appeared coincidentally, or because they share some common immunopathogenetic mechanisms. In this patient, Crohn's disease favorably responded to the treatment with an anti-TNF-α agent (adalimumab). The serum titers of antimitochondrial antibodyies and cholestatic enzymes considerably reduced during the 3-year treatment with the biologic agent. Raynaud's phenomenon, also, completely disappeared. Bearing in mind the possible involvement of TNF-α in the pathogenesis of primary biliary cirrhosis, it could be argued that the clinical and laboratory improvement of liver disease, as well as the reduction in serum titers of antimitochondrial antibodies, might be due to the anti-TNF-α action of adalimumab. We suggest that it would be worth further investigating the role of biologic agents in the treatment of patients with primary biliary cirrhosis.

[1]  C. Gluud,et al.  Ursodeoxycholic acid for primary biliary cirrhosis. , 2012, The Cochrane database of systematic reviews.

[2]  F. Fostira,et al.  Turner's syndrome, autoimmune thyroiditis, and Crohn's disease in the same patient: a combination emphasizing the role of X-chromosome in inflammatory bowel disease patients. , 2010, Inflammatory bowel diseases.

[3]  F. Lammert,et al.  EASL Clinical Practice Guidelines: management of cholestatic liver diseases. , 2009, Journal of hepatology.

[4]  R. Scrivo,et al.  Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis. , 2008, Joint, bone, spine : revue du rhumatisme.

[5]  C. Eun,et al.  Development of Primary Biliary Cirrhosis in a Patient with Crohn's Disease: A Case Report and Review of the Literature , 2005, Digestive Diseases and Sciences.

[6]  P. Gionchetti,et al.  Anti‐Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases , 2003, Clinical and experimental immunology.

[7]  E. Dickson,et al.  Tumor necrosis factor‐α and transforming growth factor‐β reflect severity of liver damage in primary biliary cirrhosis , 2002 .

[8]  E. Dickson,et al.  Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. , 2002, Journal of gastroenterology and hepatology.

[9]  A. Tanaka,et al.  Detection of antimitochondrial autoantibodies in immunofluorescent AMA‐negative patients with primary biliary cirrhosis using recombinant autoantigens , 2001, Hepatology.

[10]  T. Therneau,et al.  Epidemiology and natural history of primary biliary cirrhosis in a US community. , 2000, Gastroenterology.

[11]  T. Therneau,et al.  Epidemiology and natural history of primary biliary cirrhosis in a US community. , 2000, Gastroenterology.

[12]  A. Floreani,et al.  Tumour necrosis factor alpha and cellular proliferation in primary biliary cirrhosis. , 1999, Italian journal of gastroenterology and hepatology.

[13]  M. Manns,et al.  The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis. , 1998, Journal of hepatology.

[14]  M. Kaplan,et al.  Primary Biliary Cirrhosis , 1987, The New England journal of medicine.

[15]  K. Lindor,et al.  Primary biliary cirrhosis , 1998, Springer Netherlands.

[16]  B. Combes,et al.  Ursodeoxycholic Acid in Primary Biliary Cirrhosis , 1997, Seminars in liver disease.

[17]  N. Diamant,et al.  Primary Biliary Cirrhosis, Sicca Complex, and Dysphagia , 1997, Dysphagia.

[18]  L. Bostad,et al.  A follow-up study of 68 patients with anti-mitochondrial antibodies (AMA). , 2009, Acta medica Scandinavica.

[19]  R. Bernstein.  ANTINUCLEAR ANTIBODIES IN PRIMARY BILIARY CIRRHOSIS , 1982, The Lancet.

[20]  E. Christensen,et al.  Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. , 1980, Gastroenterology.